Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Apr;18(4):247-251.
doi: 10.1200/OP.21.00780. Epub 2022 Feb 2.

Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer

Keerthi Gogineni  1 , Kevin Kalinsky  1
Affiliations
Editorial

Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer

Keerthi Gogineni et al. JCO Oncol Pract. 2022 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Keerthi GogineniHonoraria: AmerisourceBergenConsulting or Advisory Role: PfizerResearch Funding: Pfizer (Inst), Calithera Biosciences (Inst), Merck (Inst), Genentech (Inst), Seattle Genetics (Inst), Genentech (Inst) Kevin KalinskyStock and Other Ownership Interests: Array BioPharma (I), Pfizer (I), GRAIL (I)Consulting or Advisory Role: BioTheranostics, Lilly, Pfizer, Novartis, Eisai, AstraZeneca, Genentech/Roche, Immunomedics, Ipsen, Merck, Seattle Genetics, Cyclacel, OncoSec, 4D Pharma, Daiichi Sankyo/Astra Zeneca, Puma BiotechnologySpeakers' Bureau: LillyResearch Funding: Incyte (Inst), Novartis (Inst), Genentech/Roche (Inst), Lilly (Inst), Pfizer (Inst), Calithera Biosciences (Inst), Immunomedics (Inst), Acetylon Pharmaceuticals (Inst), Seattle Genetics (Inst), Amgen (Inst), Zeno Pharmaceuticals (Inst), CytomX Therapeutics (Inst)Travel, Accommodations, Expenses: Lilly, AstraZeneca, PfizerOther Relationship: Immunomedics, GenentechNo other potential conflicts of interest were reported.

Publication types